Shimada Hiroshi, Endo Itaru, Fujii Yoshiro, Kunihiro Osamu, Tanaka Kuniya, Misuta Koichiro, Togo Sinji
Department of Surgery II, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan.
Hepatogastroenterology. 2002 Mar-Apr;49(44):300-5.
BACKGROUND/AIMS: Several surgical procedures from hilar bile duct resection to hepatectomy have been adopted for hilar cholangiocarcinoma. However the details of the surgical procedure and the indications for hilar bile duct resection have not been determined.
Pathohistological outcome of resected specimens in five patients undergoing extended hilar bile duct resection was reviewed and compared with 12 patients undergoing partial hepatectomy with caudate lobectomy.
Extended hilar bile duct resection was used for older patients, cases of choledochal site and less invasive tumor. The mean lengths of the left hepatic duct (21.7 +/- 7.8 mm) and the anterior hepatic duct (18.0 +/- 3.2 mm) in the specimens resected by extended hilar bile duct resection did not differ from those seen in right and left hepatectomy, respectively. Furthermore, extended hilar bile duct resection removed partial caudal hepatic duct. However the length of the posterior hepatic duct removed by extended hilar bile duct resection (14.3 +/- 2.0 mm) was significantly less than that excised in left hepatectomy (19.3 +/- 6.6 mm) (P < 0.05). The histologic positive margin rate of the extended hilar bile duct resection group (40%) was the same as that of the hepatectomy group (50%). Papillary or nodular form tumor tended to have positive ductal margins in both surgical techniques. On the other hand, flat tumor tended to have high positive rates in both ductal and excisional margins even in hepatectomy. Two cases with positive surgical margin died of local recurrences, however another 3 cases with negative surgical margin are alive without recurrences from 8 to 20 months after surgery.
The indication of extended hilar bile duct resection for hilar cholangiocarcinoma is limited to cases in which the infiltration is confined to the hepatic bifurcation, such as type I and type II of Bismuth classification with regard to papillary and nodular macroscopic appearance.
背景/目的:对于肝门部胆管癌,已采用了从肝门部胆管切除到肝切除术等多种手术方法。然而,手术操作的细节以及肝门部胆管切除的指征尚未确定。
回顾了5例行扩大肝门部胆管切除术患者切除标本的病理组织学结果,并与12例行肝部分切除术加尾状叶切除术的患者进行比较。
扩大肝门部胆管切除术用于老年患者、胆总管部位病例及侵袭性较小的肿瘤。扩大肝门部胆管切除术切除标本中左肝管(21.7±7.8mm)和肝前管(18.0±3.2mm)的平均长度分别与右半肝切除术和左半肝切除术中所见的长度无差异。此外,扩大肝门部胆管切除术切除了部分尾侧肝管。然而,扩大肝门部胆管切除术切除的肝后管长度(14.3±2.0mm)明显短于左半肝切除术切除的长度(19.3±6.6mm)(P<0.05)。扩大肝门部胆管切除术组的组织学切缘阳性率(40%)与肝切除术组(50%)相同。在两种手术技术中,乳头状或结节状肿瘤的导管切缘往往为阳性。另一方面,即使在肝切除术中,扁平状肿瘤在导管切缘和切除切缘的阳性率也往往较高。2例手术切缘阳性的患者死于局部复发,然而另外3例手术切缘阴性的患者在术后8至20个月存活且无复发。
肝门部胆管癌扩大肝门部胆管切除术的指征仅限于浸润局限于肝门分叉处的病例,如Bismuth分类中I型和II型的乳头状和结节状大体外观。